Tvardi Therapeutics, Inc. (TVRD) Discusses Phase 1 Data on TTI-109 STAT3 Inhibitor Highlighting Prodrug Design, Tolerability and Target Engagement Transcript

출처: Seeking Alpha Market News · 원문 보기

YOUFIRE · you-are-fire.com